COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities

Clinical trial NCT04860258 · TERMINATED

Trial details

NCT number: NCT04860258
Sponsor: CureVac
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronavirus Covid19 SARS-CoV-2 Severe Acute Respiratory Syndrome

Start date: 2021-04-22
Primary completion: 2021-09-21
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.